EDOC:NSD-Global X Telemedicine & Digital Health ETF (USD)

ETF | Others |

Last Closing

USD 9.39

Change

-0.15 (-1.57)%

Market Cap

USD 0.05B

Volume

8.70K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+1.01 (+0.51%)

USD 27.30B
ACWI iShares MSCI ACWI ETF

-0.21 (-0.19%)

USD 18.79B
IBIT iShares Bitcoin Trust

-0.60 (-1.58%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

-0.14 (-0.79%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.02 (+0.04%)

USD 14.10B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.02 (+0.08%)

USD 2.80B
IBTF iShares iBonds Dec 2025 Term T..

+0.02 (+0.09%)

USD 2.31B
NVDL GraniteShares 2x Long NVDA Dai..

+2.93 (+3.75%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

+0.14 (+0.22%)

USD 2.01B

ETFs Containing EDOC

HDOC:CA 98.44 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.21% 18% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.21% 17% F 37% F
Trailing 12 Months  
Capital Gain -17.12% 15% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.12% 15% F 34% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -14.11% 7% C- 23% F
Dividend Return -14.11% 6% D- 22% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.84% 36% F 82% B
Risk Adjusted Return -95.05% 3% F 8% B-
Market Capitalization 0.05B 51% F 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.